MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells

Blood

Volumn 90, Issue 5, 1997, Pages 1982-1992

  Teoh, Gerrard ^b   Urashima, Mitsuyoshi ^b   Ogata, Atsushi ^b   Chauhan, Dharminder ^b   DeCaprio, James A ^b   Treon, Steven P ^b   Schlossman, Robert L ^b   Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER THERAPY; CELL NUCLEUS INCLUSION BODY; CELL PROLIFERATION; CELL SURVIVAL; DOUBLE MINUTE CHROMOSOME; GENE THERAPY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030921866     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.5.1982     Document Type: Article

References (51)

1. Hamlin JL, Milbrandt JD, Heintz NH, Azizkhan JC: DNA sequence amplification in mammalian cells. Int Rev Cytol 90:31, 1984
2. Schimke RT: Gene amplification in cultured animal cells. Cell 37:705, 1984
3. Stark GR, Wahl GM: Gene amplification. Annu Rev Biochem 53:447, 1984
4. George DL, Powers VE: Amplified DNA sequences associated with double minutes of a 3T3 mouse cell line, in Schimke R (ed): Gene Amplification. Plainview, NY, Cold Spring Harbor Laboratory, 1982
5. Cahilly-Snyder L, Yang-Feng T, Francke U, George DL: Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet 13:235, 1987
6. Fakharzadeh SS, Trusko SP, George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10:1565, 1991
7. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80, 1992
8. Heighway J, Mitchell ELD, Jones D, White GRM, Koref MFS: A transcribed polymorphism and sublocalisation of MDM2. Hum Genet 93:611, 1994
9. Chen J, Marechal V, Levine AJ: Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol 13:4107, 1993
10. Boddy MN, Freemont PS, Borden KLB: The p53-associated protein MDM2 contains a newly characterized zinc-finger domain called the RING finger. Trends Biochem Sci 19:188, 1994
11. Martin K, Trouche D, Hagemeier C, Srensen TS, La Thangue NB, Kouzarides T: Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375:691, 1995
12. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang C-M, Livingston DM: The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085, 1989
13. Finlay CA: The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol Cell Biol 13:301, 1993
14. Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M: The human MDM-2 oncogene is overexpressed in leukemias. Blood 82:2617, 1993
15. Quesnel B, Preudhomme C, Oscier D, Lepelley P, Collyn d'Hooge M, Facon T, Zandecki M, Fenaux P: Over-expression of the MDM2 gene is found in some cases of haematological malignancies. Br J Haematol 88:415, 1994
16. Bueso-Ramos CE, Manshouri T, Haidar MA, Huh YO, Keating MJ, Atbitar M: Multiple patterns of MDM-2 deregulation in human leukemias: Implications in leukemogenesis and prognosis. Leuk Lymphoma 17:13, 1995
17. Zhou M, Yeager AM, Smith SD, Findley HW: Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 85:1608, 1995
18. Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, Murate T, Saito H: The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 84:3158, 1994
19. Finnegan MC, Goepel JR, Royds J, Hancock BW, Goyns MH: Elevated levels of MDM-2 and p53 expression are associated with high grade non-Hodgkin's lymphomas. Cancer Lett 86:215, 1994
20. Marks DI, Vonderheid EC, Kurz BW, Bigler RD, Sinha K, Morgan DA, Sukman A, Nowell PC, Haines DS: Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome. Br J Haematol 92:890, 1996
21. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B: p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231, 1993
22. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54:794, 1994
23. Nakayama T, Toguchida J, Wadayama B, Kanoe H, Kotoura Y, Sasaki MS: MDM2 gene amplification in bone and soft-tissue tumors: Association with tumor progression in differentiated adipose-tissue tumors. Int J Cancer 64:342, 1995
24. Zou M, Shi Y, al-Sedairy S, Hussain SS, Farid NR: The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis. Cancer 76:314, 1995
25. Sheikh MS, Shao ZM, Hussain A, Fontana JA: The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res 53:3226, 1993
26. Quesnel B, Preudhomme C, Fournier J, Fenaux P, Peyrat JP: MDM2 gene amplification in human breast cancer. Eur J Cancer 30A:982, 1994
27. McCann AH, Kirley A, Carney DN, Corbally N, Magee HM, Keating G, Dervan PA: Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. Br J Cancer 71:981, 1995
28. Marchetti A, Buttitta F, Girlando S, Dalla Palma P, Pellegrini S, Fina P, Doglioni C, Bevilacqua G, Barbareschi M: mdm2 gene alterations and mdm2 protein expression in breast carcinoma. J Pathol 175:31, 1995
29. Marchetti A, Buttitta F, Pellegrini S, Merlo G, Chella A, Angeletti CA, Bevilacqua G: mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations. Diagn Mol Pathol 4:93, 1995
30. Rizzo MG, Soddu S, Tibursi G, Calabretta B, Sacchi A: Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. Clin Exp Metastasis 11:368, 1993
31. Arany I, Rady P, Evers BM, Tyring SK, Townsend CM Jr: Analysis of multiple molecular changes in human endocrine tumours. Surg Oncol 3:153, 1994
32. He J, Reifenberger G, Liu L, Collins VP, James CD: Analysis of glioma cell lines for amplification and overexpression of MDM2. Genes Chromosomes Cancer 11:91, 1994
33. Lukas Z, Vojtesek B, Anton M, Picksley SM, Kubalek V: Overexpression of p53 and MDM2 proteins in cervical neoplasia. Folia Biol (Praha) 41:197, 1995
34. Barbareschi M, Girlando S, Fellin G, Graffer U, Luciani L, Dalla Palma P: Expression of mdm-2 and p53 protein in transitional cell carcinoma. Urol Res 22:349, 1995
35. Cheng YT, Li YL, Wu JD, Long SB, Tzai TS, Tseng CC, Lai MD: Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines. Mol Carcinog 13:173, 1995
36. Riou G, Barrois M, Prost S, Terrier MJ, Theodore C, Levine AJ: The p53 and mdm-2 genes in human testicular germ-cell tumors. Mol Carcinog 12:124, 1995
37. Landers JE, Haines DS, Strauss JF III, George DL: Enhanced translation: A novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 9:2746, 1994
38. Forus A, Flørenes VA, Mœlandsmo GM, Meltzer PS, Fodstad Ø, Mylkebost O: Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: Some amplica do not include MDM2. Cell Growth Diff 4:1065, 1993
39. Flørenes VA, Mælandsmo GM, Forus A, Andreassen Å, Mykelbost O, Fodstad Ø: MDM2 gene amplification and transcript levels in human sarcomas: Relationship to TP53 gene status. J Natl Cancer Inst 86:1297, 1994
40. Ridge SA, Dyer M, Greaves MF, Wiedemann LM: Lack of MDM2 amplification in human leukaemia. Br J Haematol 86:407, 1994
41. Kondo S, Barnett GH, Hara H, Morimura T, Takeuchi J: MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene 10:2001, 1995
42. Price BD, Park SJ: DNA damage increases the level of MDM2 messenger RNA in wtp53 human cells. Cancer Res 54:896, 1994
43. Olson DC, Marechal V, Momand J, Chen J, Romocki C, Levine AJ: Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 8:2353, 1993
44. Tishler RB, Calderwood SK, Coleman CN, Price BD: Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 53:2212, 1993
45. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B, Levine AJ: Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells. Cell Growth Diff 1:571, 1990
46. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237, 1992
47. Zauberman A, Flusberg D, Haupt Y, Barak Y, Oren M: A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res 23:2584, 1995
48. Xiao Z-X, Chen J, Levine AJ, Modjtahedi N, Xing N, Sellers WR, Livingston DM: Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694, 1995
49. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805, 1993
50. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169, 1994
51. Dulic V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Harper JW, Elledge SJ, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013, 1994